These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action. Delomenie C; Wautier-Pepin MP; Chappey O; Wautier JL Exp Cell Res; 1993 Jul; 207(1):122-30. PubMed ID: 7686496 [TBL] [Abstract][Full Text] [Related]
23. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta. Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531 [TBL] [Abstract][Full Text] [Related]
24. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin- and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor. Sayers TJ; Wiltrout TA; Bull CA; Denn AC; Pilaro AM; Lokesh B J Immunol; 1988 Sep; 141(5):1670-7. PubMed ID: 3261759 [TBL] [Abstract][Full Text] [Related]
25. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes. Batten P; Yacoub MH; Rose ML Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424 [TBL] [Abstract][Full Text] [Related]
26. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma. Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257 [TBL] [Abstract][Full Text] [Related]
28. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Kim CK; Rivier C J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649 [TBL] [Abstract][Full Text] [Related]
30. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. Doukas J; Pober JS J Immunol; 1990 Sep; 145(6):1727-33. PubMed ID: 1697308 [TBL] [Abstract][Full Text] [Related]
31. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. Albanesi C; Cavani A; Girolomoni G J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425 [TBL] [Abstract][Full Text] [Related]
32. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083 [TBL] [Abstract][Full Text] [Related]
33. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10. Fukuda T; Hisadome M; Komatsu H J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779 [TBL] [Abstract][Full Text] [Related]
34. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells. IL-1 beta-mediated induction regulated by tumor necrosis factor-alpha and IFN-gamma. Suschek C; Rothe H; Fehsel K; Enczmann J; Kolb-Bachofen V J Immunol; 1993 Sep; 151(6):3283-91. PubMed ID: 7690801 [TBL] [Abstract][Full Text] [Related]
35. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. Marfaing-Koka A; Devergne O; Gorgone G; Portier A; Schall TJ; Galanaud P; Emilie D J Immunol; 1995 Feb; 154(4):1870-8. PubMed ID: 7530744 [TBL] [Abstract][Full Text] [Related]
36. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Larsen CG; Anderson AO; Oppenheim JJ; Matsushima K Immunology; 1989 Sep; 68(1):31-6. PubMed ID: 2478449 [TBL] [Abstract][Full Text] [Related]
37. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Libert C; Brouckaert P; Shaw A; Fiers W Eur J Immunol; 1990 Mar; 20(3):691-4. PubMed ID: 2318254 [TBL] [Abstract][Full Text] [Related]
38. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Pang L; Knox AJ Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. Chung IY; Benveniste EN J Immunol; 1990 Apr; 144(8):2999-3007. PubMed ID: 2109008 [TBL] [Abstract][Full Text] [Related]
40. Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. Briscoe DM; Cotran RS; Pober JS J Immunol; 1992 Nov; 149(9):2954-60. PubMed ID: 1383333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]